Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Prolia (denosumab) Disease area(s): Bone health Manufacturer(s): Amgen 2024 Sales (USD): $4.37 billion Why it sold so well: In 2024, Amgens Prolia achieved strong sales, with global revenues increasing by 8% year-over-year to $4.37 billion for the year, driven primarily by volume growth
Animal studies show Zofran in breast milk
There have been anecdotal reports of unintended pregnancies in women who had previously been told conception would be difficult a reminder that improved hormonal regulation can have real-world reproductive consequences
Mr Bonenti said UQ researchers hoped to improve public education through their research and testing of unapproved peptides
JAMA Network Open, 7(8), e2423385
US$ 22.91
US$ 21.44
US$ 20.49
US$ 19.99
